GlassScriptPhysician profile
Patrick F Doherty
NPI 1578620282
$71,839.57
in general payments reported to CMS, 2019-2025
27 companies · $8,511 in 2025
The $8,511 reported for 2025 was more than what 84% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $7,776 · 2021: $5,047 · 2022: $5,542 · 2023: $7,347 · 2024: $16K · 2025: $8,511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Travel and Lodging: $5,360 · Food and Beverage: $4,771 · Royalty Or License: $3,734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,350.00 |
| Travel and Lodging | $5,360.07 |
| Food and Beverage | $4,771.28 |
| Royalty Or License | $3,733.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Royal Biologics, INC. | $23,987.21 | 2021-2025 | Fibrinet |
| Spineart Sa | $16,134.00 | 2019-2020 | |
| Globus Medical, INC. | $14,142.85 | 2019-2025 | Creo Mis Stabilization System, Excelsiusgps Robotic Navigation System, Excelsius Gps |
| Kuros Biosciences USA, INC | $6,742.13 | 2024-2025 | Magnetos |
| Atlas Spine, INC. | $6,285.65 | 2019 | |
| Spineart USA INC | $649.33 | 2019-2021 | |
| Spineology INC. | $444.63 | 2021 | |
| Abbott Laboratories | $420.85 | 2019-2020 | |
| Integrity Implants INC. | $417.36 | 2019-2022 | |
| Si-Bone, INC. | $358.00 | 2023-2025 | |
| Alphatec Spine, INC | $345.38 | 2022 | |
| Medtronic, INC. | $337.94 | 2021-2023 | Catalyft Pl Expandable Interbody System |
| Biocomposites INC | $327.79 | 2024-2025 | Stimulan |
| Stryker Corporation | $244.98 | 2021 | |
| Integrity Implants INC. Dba Accelus | $211.08 | 2023-2024 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lenoss Medical INC | $149.58 | 2023-2024 | Access & Cavity Creation Kit |
| Orthofix Medical, INC. | $126.20 | 2023-2024 | Osteostrand Plus, Spinal-Stim, Spinal-Stim |
| Boston Scientific Corporation | $124.71 | 2021 | |
| Benvenue Medical INC | $89.68 | 2019 | |
| Vertos Medical, INC. | $88.89 | 2023 | Mild Device Kit |
| Medtronic USA, INC. | $81.62 | 2019-2020 | |
| Nevro Corp. | $25.92 | 2024 | Senza |
| Lemaitre Vascular, INC. | $23.70 | 2022 | |
| Abbvie INC. | $23.55 | 2023 | Botox |
| Spinal Simplicity, LLC | $22.31 | 2024 | Ha Minuteman G3-R |
| Theragen, INC. | $18.13 | 2024 | Actastim-S |
| Paradigm Spine, LLC | $16.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Doherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.